Literature DB >> 11675207

Emergency surgery for retrograde extension of type B dissection after endovascular stent graft repair.

M Totaro1, F Miraldi, F Fanelli, G Mazzesi.   

Abstract

Endovascular stent graft repair of type B dissection is a new and alternative treatment to the surgical or medical therapy. This technique is not free from minor or major complications and we herein report the case of a patient who developed a retrograde dissection after endovascular stent graft placement. The emergent surgical treatment undertaken consisted of ascending aorta replacement without treating the arch in account of the presence of the endoluminal prosthesis.

Entities:  

Mesh:

Year:  2001        PMID: 11675207     DOI: 10.1016/s1010-7940(01)00957-5

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

1.  Unusual complications of endovascular repair of the thoracic aorta: MDCT findings.

Authors:  T Valente; G Rossi; F Lassandro; G Rea; M Marino; G Dialetto; R Muto; M Scaglione
Journal:  Radiol Med       Date:  2012-01-07       Impact factor: 3.469

2.  CT appearance of complications related to thoracic endovascular aortic repair (TEVAR): a pictorial essay.

Authors:  U Pua; K H Tay; B S Tan; M M Htoo; M Sebastian; K Sin; Y L Chua
Journal:  Eur Radiol       Date:  2009-01-14       Impact factor: 5.315

Review 3.  TEVAR for type B aortic dissection in Japan.

Authors:  Akihiko Usui
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-12-10

4.  Outcome of open and endovascular repair in acute type B aortic dissection: a retrospective and observational study.

Authors:  Pasquale Mastroroberto; Francesco Onorati; Saverio Zofrea; Attilio Renzulli; Ciro Indolfi
Journal:  J Cardiothorac Surg       Date:  2010-04-09       Impact factor: 1.637

5.  An adaptive optimal viewing angle determination algorithm for TEVAR operation.

Authors:  Weiya Sun; Guanyu Yang; Yang Chen; Huazhong Shu
Journal:  BMC Med Imaging       Date:  2021-10-02       Impact factor: 1.930

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.